Autobio Diagnostics Co. Ltd. logo

Autobio Diagnostics Co. Ltd. (603658)

Market Open
11 Aug, 06:57
SSE SSE
¥
33. 11
+0.26
+0.7915%
¥
23.03B Market Cap
- P/E Ratio
4.21% Div Yield
680,000 Volume
- Eps
¥ 32.85
Previous Close
Add Transaction
Day Range
32.6 33.18
Year Range
28.18 42.66
Want to track 603658 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603658 trading today higher at ¥33.11, an increase of 0.7915% from yesterday's close, completing a monthly increase of 12.7341% or ¥3.74. Over the past 12 months, 603658 stock lost -6.5481%.
603658 pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in In 9 months on Jun 01, 2027 for a total of ¥1.31.
The last earnings report, released on Apr 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0267%, based on the last three reports.
Autobio Diagnostics Co. Ltd. has completed 1 stock splits, with the recent split occurring on May 27, 2021.
The company's stock is traded on one exchange.

603658 Chart

People also search for

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
¥ 140.8
+0.7369%
Shanghai United Imaging Healthcare Co., Ltd.
¥ 112.74
+0.0355%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
¥ 30.71
+0.8207%
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
¥ 140
+2.1898%
Beijing Tiantan Biological Products Co., Ltd.
¥ 12.85
+0.5477%

Autobio Diagnostics Co. Ltd. (603658) FAQ

What is the stock price today?

The current price is ¥33.11.

On which exchange is it traded?

Autobio Diagnostics Co. Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603658.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.21%.

What is its market cap?

As of today, the market cap is 23.03B.

Has Autobio Diagnostics Co. Ltd. ever had a stock split?

Autobio Diagnostics Co. Ltd. had 1 splits and the recent split was on May 27, 2021.

Autobio Diagnostics Co. Ltd. Profile

Biotechnology Industry
Healthcare Sector
Mr. Rui Kuan Fang CEO
SSE Exchange
CNE100002GC4 ISIN
CN Country
5,539 Employees
1 Jun 2026 Last Dividend
27 May 2021 Last Split
- IPO Date

Overview

Autobio Diagnostics Co., Ltd., headquartered in Zhengzhou, China, specializes in the research, development, production, marketing, sale, and service of clinical diagnostic products. Since its establishment in 1998, Autobio has focused on creating innovative diagnostics solutions across various fields such as immunoassay, biochemistry, and microbiology. Initially known as Lifeclone Diagnostics Co., Ltd., the company rebranded to Autobio Diagnostics Co., Ltd. in 2003. Operating under Zhengzhou Autobio Co., Ltd. as its subsidiary, Autobio not only leads in diagnostics technologies but also provides extensive biological research, development, technical, and support services, making it a comprehensive player in the global diagnostics market.

Products and Services

  • Immunoassay Products:

    Autobio offers a variety of immunoassay analyzers and devices tailored to different laboratory sizes and needs. This includes:

    • AutoLumo A1860: Designed for small and medium-size labs, enhancing user experience with precise automation.
    • AutoLumo A2000 Plus: An advanced automatic chemiluminescence immunoassay analyzer for high-throughput environments.
    • AutoLumo A1000: Focused on automated chemiluminescence immunoassay analysis, suitable for a range of laboratory scales.
    • LUmo microplate luminometers, PHOmo microplate readers, iWO, and iWO-960 microplate washers: Complementary equipment for immunoassay testing, enhancing efficiency and accuracy.
  • Microbiology Products:

    Enhancing the efficiency and effectiveness of microbial detection and analysis, the company provides:

    • BC60 & BC120: Automated blood culture systems aimed at streamlining the process of blood culture analysis.
    • MALDI-TOF MS system: A cutting-edge system for the rapid identification of pathogenic bacteria.
    • AutoMic-I60: For microbial identification and antibiotic susceptibility testing, streamlining microbial analysis.
    • AutoMimo 1200: An instrument designed to optimize lab workflows with improved pipetting efficiency.
  • Molecular Diagnostics:

    Leading the way in molecular diagnostics, Autobio has developed:

    • AutoMolec 1600 & AutoMolec 3000: Integrated, automated molecular diagnostics analyzers for in vitro molecular detection, catering to the growing needs of molecular diagnostics laboratories.
  • Additional Laboratory Solutions:

    Apart from these main product categories, Autobio also supplies other laboratory essentials such as blood culture bottles, AST cards, mycoplasma TIES, and AUTOF MS reagents. These supplemental products ensure laboratories are well-equipped to perform a wide range of diagnostic tests.

  • Biological Research and Development:

    Autobio is committed to pushing the boundaries of diagnostic science through continuous biological research and development. This venture not only feeds into the innovation of new products but also supports the improvement of existing ones.

  • Technical and Support Services:

    The company provides comprehensive technical and support services, ensuring that their clients can maximize the utility and efficiency of Autobio's diagnostic solutions. This holistic approach guarantees customer satisfaction and the reliability of diagnostics operations.

Contact Information

Address: No. 199, Jingkai 15th Street, Zhengzhou, China, 450016
Phone: 86 40 0056 9995